InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Hopkinson Craig C., Executive. Officer active across 2 companies, notably Alkermes plc.. In total, 52 reports have been published. Breakdown: 0 buy · 15 sells. Total volume traded: €4.4m. History available since 9 June 2021. The latest transaction was disclosed on 3 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hopkinson Craig C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
104 shares@ US$19.340.0000% mcap0.0% of flowOrdinary SharesSEC:0001520262-26-000110:0
4,896 shares@ US$24.590.0015% mcap1.1% of flowOrdinary SharesSEC:0001520262-26-000110:1
9,000 shares@ US$48.580.0053% mcap4.1% of flowOrdinary SharesSEC:0001520262-26-000110:2
5,000 sharesOrdinary SharesSEC:0001520262-26-000103:0
8,300 sharesOrdinary SharesSEC:0001520262-26-000103:1
700 sharesOrdinary SharesSEC:0001520262-26-000103:2
5,000 shares@ US$19.340.0018% mcap1.2% of flowOrdinary SharesSEC:0001520262-26-000097:0
9,000 shares@ US$41.67150.0070% mcap4.6% of flowOrdinary SharesSEC:0001520262-26-000097:1
5,000 shares@ US$19.340.0010% mcap1.1% of flowOrdinary SharesSEC:0001520262-26-000072:0
9,000 shares@ US$33.39550.0032% mcap3.5% of flowOrdinary SharesSEC:0001520262-26-000072:1
5,000 shares@ US$19.341.1% of flowOrdinary SharesSEC:0001520262-26-000065:0
9,000 shares@ US$35.51163.6% of flowOrdinary SharesSEC:0001520262-26-000065:1
5,000 shares@ US$19.341.0% of flowOrdinary SharesSEC:0001520262-26-000058:0
6,866 sharesOrdinary SharesSEC:0001520262-26-000046:0
7,689 sharesOrdinary SharesSEC:0001520262-26-000033:0
8,897 sharesOrdinary SharesSEC:0001520262-26-000026:0
25,352 sharesOrdinary SharesSEC:0001520262-26-000016:0
5,000 shares@ US$19.341.0% of flowOrdinary SharesSEC:0001520262-26-000009:0
5,000 shares@ US$19.341.0% of flowOrdinary SharesSEC:0001520262-26-000004:0
4,000 shares@ US$28.001.1% of flowOrdinary SharesSEC:0001520262-26-000002:0
3,748 shares@ US$19.340.8% of flowOrdinary SharesSEC:0001520262-25-000014:0
4,000 shares@ US$29.301.3% of flowOrdinary SharesSEC:0001520262-25-000012:0
5,000 shares@ US$19.341.1% of flowOrdinary SharesSEC:0001520262-25-000010:0
5,000 shares@ US$19.341.1% of flowOrdinary SharesSEC:0001520262-25-000008:0
6,866 sharesOrdinary SharesSEC:0001127602-25-007313:0
25 of 52 declarations
About Hopkinson Craig C.
Hopkinson Craig C. is an executive linked to Alkermes plc., where he is EVP R&D, Chief Medical Officer, and to Albireo Pharma, INC., where he is Director. He has 49 filings in total, and in the sampled recent filings from 2021-06-08 to 2026-07-01, sales amount to EUR 4017240 and the most frequent transaction nature is option exercise.
